Big Pharma Antitrust
PHILADELPHIA — The Third Circuit affirmed dismissal Wednesday of Eisai’s claims that Sanofi-Aventis monopolized the anticoagulant drug market with its marketing of Lovenox.
PHILADELPHIA — The Third Circuit affirmed dismissal Wednesday of Eisai’s claims that Sanofi-Aventis monopolized the anticoagulant drug market with its marketing of Lovenox.